levallorphan has been researched along with Body Weight in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, Y; Tagashira, E; Urano, T; Yanaura, S | 1 |
Hiramori, T; Tagashira, E; Urano, T; Yanaura, S | 1 |
Ishii, K; Nakamura, H; Shimizu, M | 1 |
Eroğlu, L; Güngör, M; Koyuncuoğlu, H; Sağduyu, H | 1 |
Senda, H | 1 |
Izumi, T; Nagase, T; Tagashira, E; Yanaura, S | 1 |
Izumi, T; Tagashira, E; Yanaura, S | 1 |
Crofford, MJ; Hui, FW; Smith, AA | 1 |
Izumi, T; Tagashire, E; Yanaura, S | 1 |
Suzuki, T; Tagashira, E; Yanaura, S | 1 |
Bianchetti, A; Guidice, A; Manara, L; Nava, F | 1 |
Walker, PA | 1 |
Opitz, K; Reimann, I | 1 |
Feinberg, A | 1 |
Peskett, WG | 1 |
Fukuda, T; Ogawa, N; Ueki, S | 1 |
Imamura, H; Maruyama, Y; Nakanishi, M | 1 |
Kasé, Y; Kikuchi, K; Kito, G; Wakita, Y; Yuizono, T | 1 |
Davis, JA; Moore, WM | 1 |
19 other study(ies) available for levallorphan and Body Weight
Article | Year |
---|---|
Studies of physical dependence on cinepazide in rats.
Topics: Animals; Barbiturates; Behavior, Animal; Body Weight; Central Nervous System Depressants; Dose-Response Relationship, Drug; Humans; Levallorphan; Morphine; Naloxone; Piperazines; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1980 |
Biphasic action of pentazocine in morphine-dependent rats.
Topics: Animals; Body Weight; Codeine; Humans; Levallorphan; Morphine Dependence; Pentazocine; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1982 |
Some altered responses in rats formerly dependent on morphine.
Topics: Analgesics, Opioid; Animals; Body Weight; Drug Tolerance; Humans; Levallorphan; Male; Morphine; Morphine Dependence; Motor Activity; Rats; Time Factors | 1978 |
The antagonizing effect of aspartic acid on morphine withdrawal and levallorphan-precipitated abstinence syndrome signs and on associated changes in brain levels of free amino acids in the rat.
Topics: Amino Acids; Animals; Aspartic Acid; Body Weight; Brain Chemistry; Humans; Levallorphan; Motor Activity; Rats; Substance Withdrawal Syndrome; Time Factors | 1979 |
[Studies on the physical dependence liability of analgesics. 5th report: Electron microscopic studies on the ultrastructural transformation of mitochondria in the cells of zona fasciculata of the adrenal cortex in morphine pellet implanted mice (author's
Topics: Adrenal Cortex; Animals; Body Weight; Drug Implants; Humans; Injections, Subcutaneous; Levallorphan; Male; Mice; Mitochondria; Mitochondrial Swelling; Morphine; Morphine Dependence; Motor Activity; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1977 |
[Physical dependence liability test of ifenprodil in rats (author's transl)].
Topics: Animals; Body Weight; Central Nervous System; Depression, Chemical; Dose-Response Relationship, Drug; Eating; Humans; Isoxsuprine; Levallorphan; Male; Morphine Dependence; Piperidines; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
Mode of antagonistic action of levallorphan in morphine-dependent rats and assessment of physical dependence liability.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Humans; Levallorphan; Male; Morphine; Morphine Dependence; Rats; Substance Withdrawal Syndrome; Time Factors | 1979 |
Inhibition of growth in young mice treated with d,1-methadone.
Topics: Animals; Animals, Newborn; Appetite Depressants; Body Weight; Depression, Chemical; Drug Tolerance; Female; Growth; Levallorphan; Methadone; Methadyl Acetate; Mice; Nalorphine; Naloxone; Reaction Time; Stereoisomerism; Time Factors | 1977 |
[A study on drug dependence using fast acting drugs].
Topics: Animals; Body Weight; Feeding Behavior; Humans; Levallorphan; Male; Meperidine; Morphine; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1975 |
Physical dependence on morphine, phenobarbital and diazepam in rats by drug-admixed food ingestion.
Topics: Animals; Body Weight; Diazepam; Diet; Feeding Behavior; Female; Humans; Levallorphan; Male; Morphine Dependence; Phenobarbital; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1975 |
Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.
Topics: Animals; Body Weight; Diarrhea; Levallorphan; Mice; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1986 |
Drugs used in labour: an obstetrician's view.
Topics: Administration, Oral; Anesthesia, Obstetrical; Antihypertensive Agents; Body Weight; Ethanol; Fear; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Labor, Obstetric; Levallorphan; Meperidine; Obstetrics; Pentazocine; Pre-Eclampsia; Pregnancy | 1973 |
Suppression of the drug-induced morphine withdrawal syndrome by cyproheptadine.
Topics: Animals; Body Weight; Cyproheptadine; Drug Tolerance; Fenfluramine; Humans; Hypothalamus; Levallorphan; Male; Morphine Dependence; Rats; Substance Withdrawal Syndrome | 1973 |
Propoxyphene hydrochloride (Darvon) a report of two cases.
Topics: Bicarbonates; Body Weight; Charcoal; Dexamethasone; Dextropropoxyphene; Drug Packaging; Female; Humans; Infant; Intubation, Intratracheal; Levallorphan; Mannitol; Narcotic Antagonists; Peritoneal Dialysis; Poisoning; Renal Dialysis; Resuscitation; Time Factors | 1973 |
Intubation of a small newborn infant.
Topics: Body Weight; Catheterization; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intubation, Intratracheal; Levallorphan; Methods; Respiration, Artificial; Respiratory Insufficiency; Umbilical Veins | 1969 |
[A study on physical dependence on thiothixene].
Topics: Animals; Behavior, Animal; Body Weight; Humans; Levallorphan; Male; Morphine Dependence; Rats; Substance-Related Disorders; Xanthenes | 1969 |
[Studies on anti-inflammatory agents. IV. On the appearance of physical dependence and analgesic activity of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6-7-tetrahydrothieno(2,3-c)pyridine (Y-3642) by repeated administration].
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Body Weight; Diet; Drug Tolerance; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Levallorphan; Male; Morphine; Pain; Pyridines; Rats; Substance-Related Disorders; Sulfhydryl Compounds; Thiophenes; Water | 1970 |
On the sites of antitsive action of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3).
Topics: Action Potentials; Animals; Antitussive Agents; Behavior, Animal; Benzoates; Binding Sites; Body Weight; Cats; Central Nervous System; Codeine; Cough; Decerebrate State; Depression, Chemical; Dogs; Electric Stimulation; Evoked Potentials; Humans; Injections, Intra-Arterial; Injections, Intravenous; Laryngeal Nerves; Levallorphan; Muscle Contraction; Parasympatholytics; Reflex; Respiration; Sensory Receptor Cells; Stimulation, Chemical; Substance Withdrawal Syndrome; Trachea | 1970 |
Response of the newborn rabbit to acute anoxia and variations due to narcotic agents.
Topics: Animals; Animals, Newborn; Apnea; Body Weight; Dyspnea; Hypoxia; Levallorphan; Meperidine; Morphine; Nalorphine; Rabbits; Respiratory Function Tests | 1966 |